Is mirtazapine augmentation effective for patients with obsessive-compulsive disorder who failed to respond to sertraline monotherapy? A placebo-controlled, double-blind, clinical trial : International Clinical Psychopharmacology

Secondary Logo

Journal Logo

Original Articles

Is mirtazapine augmentation effective for patients with obsessive-compulsive disorder who failed to respond to sertraline monotherapy? A placebo-controlled, double-blind, clinical trial

Mowla, Arasha; Baniasadipour, Haniyehb

Author Information
International Clinical Psychopharmacology 38(1):p 4-8, January 2023. | DOI: 10.1097/YIC.0000000000000415

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid